CTXR · Citius Pharmaceuticals, Inc. · Webcasts, Transcripts & Audio
$0.55
-0.02 (-3.87%)
At close · Nov 4
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company estimates that its and Citius Oncology's collective available cash resources will be sufficient to fund our operations through November 2026. We will need to raise additional capital in the future to support our operations beyond November 2026, which raises substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$15.13M
Shares
27.45M
Volume · Nov 4
138.62K
Avg daily vol (3M)
465.98K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Citius Pharmaceuticals, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Citius Pharmaceuticals, Inc. (CTXR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY24 · Q3
2024-08-13
Citius Pharmaceuticals, Inc. (CTXR) Q3 2024 Earnings Call
Diluted EPS
$-1.57
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-03
Citius Pharmaceuticals, Inc. (CTXR) Q2 2024 Earnings Call
Diluted EPS
$-1.34
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-05-18
Citius Pharmaceuticals, Inc. (CTXR) Q2 2021 Earnings Call
Revenue
$90,000
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–3 of 3 webcasts